
SynBioBeta Speaker
Shannon Hall
Pow.Bio
CEO & Co-founder
Shannon Hall is the Co-Founder and CEO of Pow.Bio, a leader in biomanufacturing innovation. Alongside co-founder and CTO Ouwei Wang, Shannon and the Pow.Bio team have developed an AI-enabled continuous fermentation platform designed to significantly reduce time to market while achieving competitive costs. This agile, scalable, and data-driven solution is revolutionizing existing infrastructure to deliver meaningful impact today. With over 25 years of experience in the life sciences sector, Shannon has played a key role in building successful platforms, leading high-performing teams, and driving the growth of multi-million dollar businesses.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Shannon
This Year
•
-
Biomanufacturing
From Proof to Production: Building a More Efficient Biomanufacturing Journey with Pow.Bio and Bühler
Biomanufacturing is entering a new phase, where customers want more than promising technology - they need proof that a true path to scale actually exists. In this session, Pow.Bio CEO Shannon Hall will share how Pow.Bio’s AI-enabled continuous fermentation platform is helping to solve the toughest challenges around scalability, commercialization, and what it really takes to move from process development to production. A key part of that story is Pow.Bio’s partnership model, including how collaboration with Bühler is helping create a more integrated, practical route to market. The talk will also look at how industrial automation is building more connected operations that support faster decisions and better economics.
Get a Ticket
Featuring

Shannon Hall
Pow.Bio
CEO & Co-founder
•
-
Biomanufacturing
From Proof to Production: Building a More Efficient Biomanufacturing Journey with Pow.Bio and Bühler
Biomanufacturing is entering a new phase, where customers want more than promising technology - they need proof that a true path to scale actually exists. In this session, Pow.Bio CEO Shannon Hall will share how Pow.Bio’s AI-enabled continuous fermentation platform is helping to solve the toughest challenges around scalability, commercialization, and what it really takes to move from process development to production. A key part of that story is Pow.Bio’s partnership model, including how collaboration with Bühler is helping create a more integrated, practical route to market. The talk will also look at how industrial automation is building more connected operations that support faster decisions and better economics.
Get a Ticket
Featuring

Shannon Hall
Pow.Bio
CEO & Co-founder
Session lineup still growing
Get a Ticket
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Get a Ticket
Featuring
Speaker Coming Soon














































































































































































































































































